- Accueil >
- Publications >
- HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Auteurs
Ivan Bièche, Florence Coussy, Rania El-Botty, Sophie Vacher, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Cécile Reyes, David Gentien, Fabien Reyal, Francesco Ricci, André Nicolas, Caterina Marchio, Anne Vincent-Salomon, Marick Laé, Elisabetta Marangoni
Résumé
Abstract
Malignant adenomyoepithelioma (AME) of the breast is an exceptionally rare form of breast cancer, with a significant metastatic potential. Chemotherapy has been used in the management of advanced AME patients, however the majority of treatments are not effective. Recent studies report recurrent mutations in the
Membres

DAVID GENTIEN
Ingénieur de recherche